Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC - Wikidata - awgldk - TriplyDB

Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC

Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC

http://www.wikidata.org/entity/Q34005333

about

Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?Antiretroviral therapy for prevention of HIV transmission: implications for Europe Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review Combining epidemiological and genetic networks signifies the importance of early treatment in HIV-1 transmission HIV treatment as prevention: contradictory perspectives from dynamic mathematical models Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study Controlling the HIV/AIDS epidemic: current status and global challenges The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention.Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited.Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009 HIV treatment as prevention: the key to an AIDS-free generation.The evolving landscape of the economics of HIV treatment and prevention.A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States.The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.Optimizing ART adherence: update for HIV treatment and prevention The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco.Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.Antiretroviral therapy: a promising HIV prevention strategy?Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies.Complexity in mathematical models of public health policies: a guide for consumers of models.Routine HIV screening in Portugal: clinical impact and cost-effectiveness.Cost effectiveness of 'on demand' HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada Responding to the National HIV/AIDS Strategy-setting the research agenda.CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009.Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.Treatment as prevention: preparing the way Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model.The Relationship Between Online Social Network Use, Sexual Risk Behaviors, and HIV Sero-Status Among a Sample of Predominately African American and Latino Men Who have Sex with Men (MSM) Social Media Users.Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria.Integrating acute HIV infection within routine public health surveillance practices in New York City.HIV treatment as prevention and HPTN 052.Universal testing and treatment as an HIV prevention strategy: research questions and methods.Modelling the impact of antiretroviral therapy on the epidemic of HIV Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study.Rapid Point-of-Care Isothermal Amplification Assay for the Detection of Malaria without Nucleic Acid Purification.A Rapid, Self-confirming Assay for HIV: Simultaneous Detection of Anti-HIV Antibodies and Viral RNA HIV incidence in men who have sex with men in England and Wales 2001-10: a nationwide population study.

P2860

Q26825761-DD90B394-03D2-4A20-8FB2-E3650F252192 Q27023464-04000154-D0CA-4585-81FB-D5C3C9CCE680 Q27026742-9BAA4224-C1B5-4E2C-AF0B-04D490E3579C Q27316777-8A59FB0E-9E34-4EDC-AEDD-ABAC35A21651 Q28080917-40762FCB-9810-4C9D-85D0-08C265036E72 Q28534568-09BCB6A0-3F10-4E57-AF41-4F9CF901F11A Q30420558-822FC2BB-58E9-4A87-856B-51A4BC582932 Q33591117-08A10BC3-9ADC-44D5-B793-AFB845218634 Q33670446-C1E674CA-F68E-471B-BE45-9F4E85A96230 Q33854542-5508F3D9-4027-4353-A1A5-84D17778062C Q34014700-D0556289-A749-44DD-BC80-F2C3C5E36835 Q34154129-B20DBC32-BE11-42DE-8DF7-91FD3FF83A57 Q34163143-CD768738-8874-4071-9F05-146D2EFD3D19 Q34163174-EB515C61-0CD6-4105-B54C-C52828156444 Q34423942-AF935FBB-A6C5-429B-847A-520651DFF325 Q34606589-2ABCDE4B-8484-403D-8C19-33FC8042704E Q34717901-EC06DBC2-F73B-4099-A6FE-16FBAC0EBC0C Q34756819-330D50CF-5772-4D72-BF6F-A4CEBB781F7A Q34760570-67E1D7C4-A506-49EF-B07D-9415FD1A1ED1 Q34781053-035C941C-7750-46FF-B7DB-8F3DC9650DAF Q34994315-30DF097A-318D-4AF1-8B79-26ABACA17F1D Q35034075-8D91930E-811F-43B1-9D9A-042E5A2AA11E Q35075697-3E2C7096-AD7F-4C4C-A365-A529201B10FC Q35158119-60C7E97D-9C3D-49C9-9CBE-A5238BA75548 Q35175520-137439DC-83C3-45A9-A1B8-CE294B4622CB Q35222957-187CD770-1069-4CA9-A751-F80D5D12EDDE Q35290298-C3260204-1A83-4867-9483-17634378F490 Q35357663-BBE4A025-67F2-4D88-BB52-C8B3A4D8CDD7 Q35651026-7776CC57-3A51-4945-9BEC-0FCD20B9C177 Q35836776-BB623546-472E-46DD-9957-C688E119C110 Q35837001-8624E8CC-353F-4376-AF33-CD7BA3C6B12A Q35962509-E0C0F8A0-E79D-46D2-B98C-49C22BC068CE Q36005278-6731D1FD-059E-4E08-883A-7C6049CD15FB Q36364604-37304AE3-ECD7-4278-8647-A71BCE1F2908 Q36460647-7BEE2937-18CA-405C-8C98-A67175CE43D8 Q36486234-37D65DF2-02E5-4307-83C9-8F03823E3F6C Q36487079-26F4EB6C-0950-4BC0-8570-1A48D12BCFE2 Q36487344-760460A5-7543-42C5-B8BE-6D394D4F0F3C Q36623511-FF369498-D1A5-43BA-9FB1-C369C9A95DC7 Q36722340-B6F537FE-4D1C-4E17-A9DF-780E50002B5C

P2860

Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC

http://www.wikidata.org/entity/Q34005333

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@ast

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@en

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@nl

type

label

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@ast

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@en

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@nl

prefLabel

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@ast

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@en

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@nl

P1433

Q34005333-EDFA6BDD-9FEF-42CC-B16B-73F35BD61198

P1476

Q34005333-97578C6A-9CFB-4DE5-BEAA-C9E734F5E53E

P2093

Q34005333-2EE57E2E-6291-41E3-9B5D-160DDC7A3AB6

Q34005333-39953EAA-1C21-496E-8A4C-298E625003A9

Q34005333-50BC93EB-6FFE-4A39-945B-77890BB3EA27

Q34005333-58DFA64C-6F04-4243-96AC-E98A211BB674

Q34005333-757A8119-989E-4B0E-89B8-30ACA5B85DFD

Q34005333-AE6BBF1C-ABBB-419F-A226-46703F0C569C

P2860

Q34005333-0479857A-2A5F-4DDD-963D-00B41E161AA8

Q34005333-0B389DAD-65F2-4C03-87CE-6219A8EC75BA

Q34005333-127A0F1F-8F54-4C0E-B400-4076FE68B36F

Q34005333-20451F5A-48BD-4275-BB6B-1A91A0EBCC90

Q34005333-2F262124-E37B-4D23-8D8E-902151279D8C

Q34005333-307F48B7-3971-4578-92B6-42ECF9733DDC

Q34005333-30AF78CC-05D5-4570-9E70-84A503247FCC

Q34005333-3516E063-33DE-4A8D-871A-A77423ACC7DC

Q34005333-3D83E282-59CF-4D7D-829F-48FD30523897

Q34005333-3DC6FD57-F157-468C-A7A5-52213A1584D6

P304

Q34005333-AC7B3499-CFFF-48E4-BC07-36AC2C92415D

P31

Q34005333-ABC02C0F-F921-4463-A6AA-2DE3A59D60D6

P356

Q34005333-04B61437-1F87-4D40-92FA-F109DF3F8D2C

P407

Q34005333-F13D1AAD-7648-4C3A-87C3-9535BA2103AF

P433

Q34005333-073B930A-62AA-4034-8B1C-E4E747DC1097

P478

Q34005333-28D9BE4E-CBDA-4023-8800-DB8E372743D2

P50

Q34005333-BEAA71D3-8E0C-486D-9932-7FE21774E0BF

Q34005333-C2617EE0-E532-4BD0-86B3-CFEF8292D63A

Q34005333-C4A98403-E1F6-4FC3-846C-7FC68C259834

P577

Q34005333-028955DE-5CB4-4744-8A3A-0C4111B3CF78

P5875

Q34005333-66950314-4B84-4743-B876-EFB4E93A0005

P698

Q34005333-FF543FEA-DF7A-4C89-AFCE-E623E89A94A8

P932

Q34005333-057A1603-B868-4B40-97A7-B39C1D30205D

P356

P1433

Clinical Infectious Diseases

P1476

Test and treat DC: forecasting ...... HIV strategy in Washington DC

@en

P2093

A David Paltiel

http://www.w3.org/2001/XMLSchema#string

Bethany L Morris

http://www.w3.org/2001/XMLSchema#string

CEPAC Investigators

http://www.w3.org/2001/XMLSchema#string

Callie A Scott

http://www.w3.org/2001/XMLSchema#string

Erin R Rhode

http://www.w3.org/2001/XMLSchema#string

George R Seage

http://www.w3.org/2001/XMLSchema#string

P2860

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

CD4+ count-guided interruption of antiretroviral treatment

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials.

Estimation of HIV incidence in the United States.

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.

The survival benefits of AIDS treatment in the United States.

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

P304

392-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/655130

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Rochelle P. Walensky

Kenneth A Freedberg

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45147211

http://www.w3.org/2001/XMLSchema#string

P698

20617921

http://www.w3.org/2001/XMLSchema#string

P932

2906630

http://www.w3.org/2001/XMLSchema#string